Citation: Jc. Ingham et G. Riley, GUIDELINES FOR DOCUMENTATION OF TREATMENT EFFICACY FOR YOUNG-CHILDRENWHO STUTTER, Journal of speech language and hearing research, 41(4), 1998, pp. 753-770
Citation: G. Riley, WRITING THE RANGE - RACE, CLASS, AND CULTURE IN THE WOMENS WEST - JAMESON,E, ARMITAGE,S, Journal of American ethnic history, 17(2), 1998, pp. 91-92
Citation: G. Riley et al., POTENTIALLY INEFFECTIVE CARE IN INTENSIVE-CARE, JAMA, the journal of the American Medical Association, 279(9), 1998, pp. 651-651
Authors:
GASTER LM
BLANEY FE
DAVIES S
DUCKWORTH DM
HAM P
JENKINS S
JENNINGS AJ
JOINER GF
KING FD
MULHOLLAND KR
WYMAN PA
HAGAN JJ
HATCHER J
JONES BJ
MIDDLEMISS DN
PRICE GW
RILEY G
ROBERTS C
ROUTLEDGE C
SELKIRK J
SLADE PD
Citation: Lm. Gaster et al., THE SELECTIVE 5-HT1B RECEPTOR INVERSE AGONIST TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4'-PIPERIDINE] (SB-224289) POTENTLY BLOCKS TERMINAL 5-HT AUTORECEPTOR FUNCTION BOTH IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 41(8), 1998, pp. 1218-1235
Authors:
THOMAS DR
GITTINS SA
COLLIN LL
MIDDLEMISS DN
RILEY G
HAGAN J
GLOGER I
ELLIS CE
FORBES IT
BROWN AM
Citation: Dr. Thomas et al., FUNCTIONAL-CHARACTERIZATION OF THE HUMAN CLONED 5-HT7 RECEPTOR (LONG FORM) - ANTAGONIST PROFILE OF SB-258719, British Journal of Pharmacology, 124(6), 1998, pp. 1300-1306
Citation: Jc. Ingham et G. Riley, BEHAVIORAL TREATMENT OF STUTTERING WITH YOUNG-CHILDREN - PROCEDURES AND RESULTS, Journal of fluency disorders, 22(2), 1997, pp. 106-106
Authors:
BAKKER K
STLOUIS K
STARKWEATHER W
RILEY G
NEILSON M
Citation: K. Bakker et al., PROGRESS REPORT ON THE DEVELOPMENT OF THE FLUENCY PROFILE - A TEST FOR THE MEASUREMENT OF SPEECH FLUENCY, Journal of fluency disorders, 22(2), 1997, pp. 121-121
Citation: S. Hatchhalili et al., CHILDRENS VOWEL DURATION AND STUTTERING MODIFICATION FOLLOWING SPEECHMOTOR TRAINING, Journal of fluency disorders, 22(2), 1997, pp. 132-132
Authors:
LEE HJ
RILEY G
JOHNSON O
CLELAND JL
KIM N
CHARNIS M
BAILEY L
DUENAS E
SHAHZAMANI A
MARIAN M
JONES AJS
PUTNEY SD
Citation: Hj. Lee et al., IN-VIVO CHARACTERIZATION OF SUSTAINED-RELEASE FORMULATIONS OF HUMAN GROWTH-HORMONE, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1431-1439
Authors:
HARNETT N
BROWN S
RILEY G
TERRO R
KRISHNAN C
PAUZE M
YEUNG KH
Citation: N. Harnett et al., ANALYSIS OF NEISSERIA-GONORRHOEAE IN ONTARIO, CANADA, WITH DECREASED SUSCEPTIBILITY TO QUINOLONES BY PULSED-FIELD GEL-ELECTROPHORESIS, AUXOTYPING, SEROTYPING AND PLASMID CONTENT, Journal of Medical Microbiology, 46(5), 1997, pp. 383-390
Citation: G. Riley et al., HEALTH-STATUS OF MEDICARE ENROLLEES IN HMO AND FEE-FOR-SERVICE IN 1994, Health care financing review, 17(4), 1996, pp. 65-76